Oxaborole Antifungal [EPC]

732 reported adverse events

Drugs of this class: TAVABOROLE TAVABOROLE TOPICAL SOLUTION, 5%

These side effects are most commonly reported by patients taking drugs of the Oxaborole Antifungal [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 124
1 APPLICATION SITE ERYTHEMA 70
2 APPLICATION SITE EXFOLIATION 55
3 APPLICATION SITE PAIN 55
4 APPLICATION SITE IRRITATION 40
5 DRUG ADMINISTERED AT INAPPROPRIATE SITE 38
6 NAIL DISCOLOURATION 38
7 ERYTHEMA 37
8 PRURITUS 34
9 SKIN EXFOLIATION 28
See all common reactions for Oxaborole Antifungal [EPC]

Drugs of the Oxaborole Antifungal [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 APPLICATION SITE FISSURE 6 0.0811
1 NAIL NECROSIS 1 0.0625
2 ONYCHOMALACIA 2 0.0370
3 MODEL FOR END STAGE LIVER DISEASE SCORE INCREASED 1 0.0345
4 YELLOW NAIL SYNDROME 1 0.0345
5 NAIL HYPERTROPHY 3 0.0216
6 APPLICATION SITE EXFOLIATION 55 0.0165
7 ONYCHOLYSIS 16 0.0159
8 NAIL DISCOMFORT 1 0.0147
9 INGROWING NAIL 24 0.0138
See all enriched reactions for Oxaborole Antifungal [EPC]